Celiac Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Celiac Disease, including details on symptoms, diagnosis, causes, diet.

Celiac disease-related antibodies in an epilepsy cohort and matched reference population.

Ranua J, Luoma K, Auvinen A, Mäki M, Haapala AM, Peltola J, Raitanen J, Isojärvi J

Department of Neurology, Seinäjoki Central Hospital, Seinä-joki, Finland. jouni.ranua@netikka.fi

Celiac disease (CD) is a common immunologically mediated enteropathic condition manifesting in genetically predisposed individuals after exposure to wheat gluten. CD may be associated with a number of neurological disorders, and the prevalence of epilepsy is reported to be increased in patients with CD. We studied the prevalence of CD-associated antibodies in a cohort of 968 patients with epilepsy and in a population-based reference group of 584 subjects. There was no difference in the prevalence of IgA and IgG class antigliadin antibodies (AGAbA and AGAbG, respectively), endomysial antibodies (EMA), and tissue transglutaminase antibodies (tTGAbA) between patients with epilepsy and the control population. This suggests the presence of CD to be the same in patients with epilepsy and the reference population. However, AGAbA was more prevalent in patients with primary generalized epilepsy (19.6%) than in the reference population (10.6%, relative risk 1.8, 95% confidence interval 1.1-3.0, P=0.012).

Published 11 April 2005 in Epilepsy Behav, 6(3): 388-92.
Full-text of this article is available online (may require subscription).

© 2005-2008 Celiac Disease Research Today. All Rights Reserved.